| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:e42.)
© 2005 American Heart Association, Inc.
Short Communications |
From the Department of Psychiatry (J.G., T.D.), Ludwig-Maximilian-Universität, Munich, Germany; Department of Neurology (A.G.), Städtisches Klinikum, Ludwigshafen, Germany; and Department of Neurology (J.G., C.L.), University of Heidelberg, Germany.
Correspondence to Dr Christoph Lichy, Department of Neurology, University of Heidelberg, INF 400 69120, Heidelberg, Germany. E-mail christoph_lichy{at}med.uni-heidelberg.de
| Abstract |
|---|
|
|
|---|
Methods We investigated high-sensitivity CRP levels in 62 patients <60 years of age experiencing cerebral ischemia resulting from large artery atherosclerosis (LAA; n=21), CAD (n=21), or cryptogenic etiology (n=20) >9 months ago, and in 54 sex- and age-matched population controls. Receiver operating characteristic curve was used to identify the best CRP cutoff level for dichotomization.
Results CRP was elevated above control levels (0.54 [0.33 to 0.84] median, interquartile range mg/L) in patients with LAA (2.59 [0.56 to 3.99] mg/L; P<0.001) and with CAD (2.37 [0.57 to 4.78] mg/L; P=0.0013) but not in patients with cryptogenic etiology (0.74 [0.14 to 7.86] mg/L). CRP levels above the cutoff level of 0.71 mg/L were independently associated with former CAD (P=0.005) but not with former LAA after adjustment for age, gender, and conventional risk factors.
Conclusion Our results strongly suggest that CRP is associated with CAD, independent from conventional risk factors, and that inflammatory mechanisms may play a role in its pathogenesis. This finding should be confirmed by larger studies.
Key Words: atherosclerosis dissection inflammation stroke young adults
| Introduction |
|---|
|
|
|---|
Because CAD is a rare condition and a prospective approach to clarify a role of CRP is not suitable, we decided to perform a retrospective study investigating the chronic-stage CRP levels in patients with former CAD and with cerebral ischemia caused by other etiologies.
| Subjects and Methods |
|---|
|
|
|---|
Serum samples were taken from resting patients and immediately stored at 70°C. CRP was determined in duplicate with a highly sensitive ELISA (Eurimmun).
MannWhitney U and t tests were used to compare 2 groups, as appropriate, KruskalWallis test for analyses across all groups, and Spearmans rank correlation coefficient for correlation analyses. Stepwise binary logistic regression served to adjust for all variables that significantly correlated with the outcome variable. Receiver operating characteristic (ROC) curve was used to define the CRP cutoff value, with a maximum sensitivity and specificity to discriminate between patients and controls.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
3 months after stroke.8 Further, in the subgroup of CAD, all patients had stable findings on follow-up magnetic resonance angiography previously. Vascular risk factors correlate with elevated CRP.9 This may explain why the association between LAA and CRP was rendered nonsignificant after adjustment for vascular risk factors. The classical risk factors do not importantly contribute to CAD, and accordingly, the association between CAD and CRP remained significant in the multivariate model. The pathogenesis of CAD is incompletely understood. Studies have shown that acute infection frequently precedes CAD, suggesting that inflammation plays a role in CAD pathogenesis.6,7 Elevation of CRP in patients with previous CAD could point to a role of chronic infection or to a genetically determined susceptibility to inflammatory stimuli. The strongest limitation of the present study is the low number of subjects in subgroups. However, our findings encourage investigation of CRP in larger populations with CAD, which should also aim to find a possible correlation with recurrency. A European multicenter study consecutively involving CAD patients is under way and hopefully will help to elucidate this important issue further.
Received November 13, 2004; revision received January 3, 2005; accepted January 27, 2005.
| References |
|---|
|
|
|---|
2. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002; 252: 283294.[CrossRef][Medline] [Order article via Infotrieve]
3. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, DAgostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001; 32: 25752579.
4. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, and Hack CE. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999; 100: 96102.
5. Grau AJ, Brandt T, Buggle F, Orberk E, Mytilineos J, Werle E, Conradt, Krause M, Winter R, Hacke W. Association of cervical artery dissection with recent infection. Arch Neurol. 1999; 56: 851856.
6. Guillon B, Berthet K, Benslamia L, Bertrand M, Bousser MG, and Tzourio C. Infection and the risk of spontaneous cervical artery dissection: a case-control study. Stroke. 2003; 34: 7981.[CrossRef]
7. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem. 2001; 47: 444450.
8. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ. An early and sustained peripheral inflammatory response in acute ischemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol. 2003; 139: 93101.[CrossRef][Medline] [Order article via Infotrieve]
9. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation. 2004; 109: 19551959.
This article has been cited by other articles:
![]() |
A. Pezzini, E. Del Zotto, G. Mazziotti, G. Ruggeri, F. Franco, A. Giossi, A. Giustina, and A. Padovani Thyroid Autoimmunity and Spontaneous Cervical Artery Dissection Stroke, September 1, 2006; 37(9): 2375 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prabhakaran, A. Khandji, and C. B. Wright Extracranial internal carotid artery dissection with unusual gadolinium enhancement Neurology, August 8, 2006; 67(3): 536 - 537. [Full Text] [PDF] |
||||
![]() |
M. Longoni, C. Grond-Ginsbach, A. J. Grau, J. Genius, S. Debette, M. Schwaninger, C. Ferrarese, and C. Lichy The ICAM-1 E469K gene polymorphism is a risk factor for spontaneous cervical artery dissection Neurology, April 25, 2006; 66(8): 1273 - 1275. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |